ZAGREB (Croatia), July 30 (SeeNews) – Croatian pharmaceuticals distributor Medika Group [ZSE:MDKA-R-A] said on Tuesday its consolidated net profit dropped by an annual 2.2% to 39.3 million kuna ($5.9 million/5.3 million euro) in the first half of the year.
Medika Group’s operating profit amounted to 51.6 million kuna in the January-June period, up 22% on the year, the company said in an unaudited first-half financial report filed with the Zagreb Stock Exchange (ZSE).
The company's consolidated total net revenue rose by an annual 16.6% to 1.8 billion kuna in the first six months of 2019.
Sales revenue amounted to 1.7 billion kuna in the period under review, up 17.1% year-on-year. Sales on the domestic market contributed 99.9% of the total figure.
Material costs increased by 17.6% on the year to 1.6 billion kuna.
The group's gross margin amounted to 8.35% in the first half of 2019, down 0.86 pp year-on-year.
Medika employed 848 people at the end of June.
(1 euro = 7.38047 kuna)